封面
市場調查報告書
商品編碼
2084815

體外膜氧合(ECMO)系統市場:依方法、應用、年齡層和地區分類。

Extracorporeal Membrane Oxygenation System Market, By Modality, By Application, By Age Group, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

體外膜氧合(ECMO)系統市場預計2026年達到3.95億美元,預計2033年將達到5.71億美元。預計從2026年到2033年,其複合年成長率將達到5.4%。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 3.95億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2033 年)複合年成長率 5.40% 預計金額(2033 年) 5.71億美元

體外膜氧合(ECMO)是一種在體外支持心肺功能的方法。根據引流和回輸的位置,ECMO系統可分為三種:動靜脈型、動靜脈型和動靜脈型。此外,ECMO系統也依年齡分為新生兒型、兒童和成人型。插管上引流和回輸端口的位置決定了ECMO系統的類型。當引流和回輸皆經由中心靜脈進行時,稱為動靜脈型ECMO;當引流和回輸均從靜脈到動脈進行時,稱為動靜脈型ECMO。 ECMO對因肺部或心臟疾病而病情嚴重的患者,以及等待或正在接受心臟移植的患者有益。當其他生命維持措施無效時,可以使用ECMO。 ECMO不能治療或治癒疾病,但可以在身體無法為組織提供足夠氧氣時暫時支持身體機能。

隨著先天性心臟疾病的增加,對體外膜氧合(ECMO)的需求也上升。例如,根據美國心臟協會的數據,美國每年約有4萬名嬰兒出生時患有先天性心臟疾病,全球約有200萬至300萬人患有先天性心臟疾病。

市場動態

ECMO市場成長的促進因素包括心血管疾病和慢性呼吸系統疾病(包括氣喘、慢性阻塞性肺病(COPD)、職業性肺病和肺動脈高壓)盛行率的不斷上升。例如,根據世界衛生組織(WHO)2022年5月發布的數據,慢性阻塞性肺病(COPD)是全球第三大死因,2019年造成323萬人死亡。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機,並描述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本頁面根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數,對全球體外膜氧合(ECMO)系統市場的主要公司進行了介紹。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
  • 《全球體外膜氧合(ECMO)系統市場》報告面向業界廣泛的相關人員,包括投資者、經銷商、產品製造商、分銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球體外膜氧合(ECMO)系統市場中使用的各種策略矩陣來促進決策。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 技術進步
  • PEST分析
  • 波特五力模型

第4章 全球體外膜氧合(ECMO)系統市場:依系統類型分類(2021-2033 年)

  • 概述
  • 動靜脈型
  • 靜脈-動脈型
  • 靜脈-靜脈型

第5章 全球體外膜氧合(ECMO)系統市場:依應用領域分類(2021-2033年)

  • 概述
  • 體外心肺復甦術(CPR)
  • 呼吸系統

第6章 全球體外膜氧合(ECMO)系統市場:依年齡層分類(2021-2033 年)

  • 概述
  • 新生
  • 兒童
  • 成人

第7章 全球體外膜氧合(ECMO)系統市場:依地區分類(2021-2033年)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • 波灣合作理事會(GCC)國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • Medtronic
  • Getinge AB
  • LivaNova PLC
  • Terumo Corporation
  • XENIOS AG
  • OriGen Biomedical
  • EUROSETS
  • NIPRO
  • MicroPort Scientific Corporation

第9章

  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI947

Extracorporeal Membrane Oxygenation System Market is estimated to be valued at USD 395 Mn in 2026 and is expected to reach USD 571 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 395 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.40% 2033 Value Projection: USD 571 Mn

Extracorporeal membrane oxygenation (ECMO) assists cardiopulmonary functions outside the body. Based on the location of drainage and reinfusion there are three different types of extracorporeal membrane oxygenation system which are arteriovenous, venoarterial, and venovenous. Whereas, on the bases of age, ECMO systems are classified into neonatal, pediatric and adult. . The location of drainage and reinfusion port of cannulas determines the modality of the ECMO system. If drainage and reinfusion both are from central veins it is referred as venovenous ECMO or if it is from vein to artery it is referred to as venoarterial ECMO. ECMO is helpful for people who are very ill with conditions of the lungs and heart, or who are awaiting for or recovering from a heart transplant. It may be used when other life support measures do not work. ECMO does not treat or cure a disease, but can assist the body temporarily when it is not able to provide the tissues with enough oxygen.

Growing number of congenital heart defects, increase demand for ECMO. For instance, according to American Heart Association, approximately 40,000 infants are born with a congenital heart defect in U.S. each year and around 2 to 3 million individuals are living with a congenital heart defect.

Market Dynamics

Growth of ECMO market is due to factors such as increasing prevalence of cardiovascular and chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), occupational lung disease or pulmonary hypertension. For instance, according to data published by the World Health Organization, in May 2022, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global extracorporeal membrane oxygenation system market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic, Getinge AB, LivaNova PLC, Terumo Corporation, XENIOS AG, OriGen Biomedical, EUROSETS NIPRO, and MicroPort Scientific Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global extracorporeal membrane oxygenation system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracorporeal membrane oxygenation system market

Market Segmentation

  • By Modality Insights (Revenue, USD Mn, 2021 - 2033)
  • Arteriovenous
  • Venoarteial
  • Venovenous
  • By Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Extracorporeal cardiopulmonary resuscitation
  • Cardiac
  • Respiratory
  • By Age Group Insights (Revenue, USD Mn, 2021 - 2033)
  • Neonatal
  • Pediatric
  • Adults
  • By Region Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players
  • Medtronic
  • Getinge AB
  • LivaNova PLC
  • Terumo Corporation
  • XENIOS AG
  • OriGen Biomedical
  • EUROSETS
  • NIPRO
  • MicroPort Scientific Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Modality
    • Market Snapshot, By Application
    • Market Snapshot, By Age Group
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Technological Advancements
  • PEST Analysis
  • PORTER'S Five Forces

4. Global Extracorporeal Membrane Oxygenation System Market, By Modality, 2021 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Arteriovenous
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Venoarteial
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Venovenous
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Extracorporeal Membrane Oxygenation System Market, By Application, 2021 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Extracorporeal cardiopulmonary resuscitation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Cardiac
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Respiratory
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Extracorporeal Membrane Oxygenation System Market, By Age Group, 2021 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Neonatal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Pediatric
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Adults
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Extracorporeal Membrane Oxygenation System Market, By Region, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • UK
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Getinge AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LivaNova PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • XENIOS AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • OriGen Biomedical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • EUROSETS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NIPRO
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MicroPort Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us